DSM-Firmenich AG's EPS (Basic) for the
six
months ended in Dec. 2025 was CHF-5.80.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was CHF-3.98.
During the past 12 months, DSM-Firmenich AG's average EPS without NRIGrowth Rate was 188.10% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was -17.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 4 years, DSM-Firmenich AG's highest 3-Year average EPS without NRI Growth Rate was -17.00% per year. The lowest was -17.00% per year. And the median was -17.00% per year.
DSM-Firmenich AG (XSWX:DSFIR) EPS (Diluted) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
DSM-Firmenich AG EPS (Diluted) Related Terms
DSM-Firmenich AG EPS (Diluted) Historical Data
* Premium members only.
The historical data trend for DSM-Firmenich AG's EPS (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:DSFIR vs LIN, SHW, ECL: EPS (Diluted) Comparison
For the Specialty Chemicals subindustry, DSM-Firmenich AG's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DSM-Firmenich AG PE Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, DSM-Firmenich AG's PE Ratio distribution charts can be found below:
* The bar in red indicates where DSM-Firmenich AG's PE Ratio falls into.
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
DSM-Firmenich AG's Diluted EPS for the fiscal year that ended in Dec. 2025 is calculated as
EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-3.98
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DSM-Firmenich AG (XSWX:DSFIR) has a EPS (Diluted) of CHF-3.98 as of Dec. 2025. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on DSM-Firmenich AG and its competitors.
Is DSM-Firmenich AG's EPS (Diluted) too high?
DSM-Firmenich AG's current EPS (Diluted) is CHF-3.98. Overall, DSM-Firmenich AG has a GF Score™ of 32/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DSM-Firmenich AG's EPS (Diluted) compare to LIN and SHW?
DSM-Firmenich AG's EPS (Diluted) of CHF-3.98 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Chemicals company?
A good EPS (Diluted) depends on the Chemicals industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on DSM-Firmenich AG and its competitors. DSM-Firmenich AG's current EPS (Diluted) is CHF-3.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DSM-Firmenich AG stock overvalued right now?
Based on GuruFocus' analysis, DSM-Firmenich AG (XSWX:DSFIR) is currently considered Fairly Valued. The stock's GF Value™ is CHF70.90, compared to a current price of CHF74.82 — trading 5.5% above its estimated fair value. The current EPS (Diluted) is CHF-3.98. DSM-Firmenich AG's overall GF Score™ is 32/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For DSM-Firmenich AG (XSWX:DSFIR), the current EPS (Diluted) is CHF-3.98 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DSM-Firmenich AG (XSWX:DSFIR) Overvalued in 2026?
Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued.
The current stock price of CHF74.82 is trading 5.5% above its estimated GF Value™ of CHF70.90.
GuruFocus considers DSM-Firmenich AG to be Fairly Valued.
Key valuation signals for XSWX:DSFIR:
EPS (Diluted): CHF-3.98
GF Value™: CHF70.90 vs. price of CHF74.82 (5.5% above fair value)
No single metric tells the full story. See the XSWX:DSFIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
32GF Score
Get the complete analysis for XSWX:DSFIR
EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DSFIR has been successfully added to your 